Brief: Sutro Biopharma FY Revenue USD 62.043 Million
13/03/2025 20:07
Mar 13 (Reuters) - Sutro Biopharma FY net income USD -227.461 million. FY operating income USD -238.453 million FY operating expenses USD 300.496 million FY basic EPS USD -2.96
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates